In the journey towards a world free of Tuberculosis (TB), the crucial first step begins with identifying individuals affected by the disease.
Study shows limited effectiveness of common local anesthetic
Liposomal bupivacaine was launched on the market twelve years ago to provide long-lasting local control of pain.